Dr. Andrew S. Bomback, MD

Dr. Bomback practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Bomback's NPI, 1013129816, was assigned on May 4, 2007. Dr. Bomback graduated from Vagelos College of Physicians and Surgeons in 2003. Dr. Bomback holds New York license 251905.

Dr. Bomback's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Bomback's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Bomback is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Bomback to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bomback practices. Vendor and product names are available with a free account.

Nephrology is Dr. Bomback's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bomback is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Bomback's licenses on file in 5 states: New York, Florida, New Jersey, Connecticut and North Carolina.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Bomback treats.

CMS data shows 637 Medicare services from Dr. Bomback across 6 procedure codes in 2024, for 208 Medicare patients. Medicare paid $74,746 for them.

CMS counts 208 Medicare patients who saw Dr. Bomback in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 3.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bomback's median patient age at 59, with 42% women.

In 2024, Dr. Bomback wrote 295 Medicare Part D claims for 75 patients. 71% of them were for generic drugs. CMS names the drug for 104 of them, across 5 drugs with 11 or more claims each, at $46,561 in total drug cost. In 2023, CMS named 92 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bomback for performance year 2024, reported through an alternative payment model (APM). Dr. Bomback accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bomback as offering telehealth.

Dmand AI links 220 papers to Dr. Bomback, published from 2007 to 2025. 2020 was the busiest year, with 22. The most frequent topics are Kidney Diseases, Kidney and Glomerular Filtration Rate. Dr. Bomback has published most often in Clin J Am Soc Nephrol. Dr. Bomback's most frequent co-authors are Gerald Bernard Appel, MD, Pietro Alessandro Ambrogio Canetta, MD and Jai Radhakrishnan, MD.

Dmand AI links Dr. Bomback to 6 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Glomerulonephritis, Glomerulonephritis, Membranous and Glomerulonephritis, IGA. Mayo Clinic sponsors the most, 2.

CMS Open Payments shows 108 general payments to Dr. Bomback from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 88% of the total. Travere Therapeutics, Inc. paid the most, $25,220. It also lists 7 research payments totaling $28,269 from 2024 to 2025.

Dr. Bomback graduated from Vagelos College of Physicians and Surgeons in 2003.

Dr. Bomback is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.